Interlaboratory reproducibility of female genital tract cytokine measurements by Luminex

Implications for microbicide safety studies

Mark E. Scott, Sarah S. Wilson, Lisa A. Cosentino, Barbra A. Richardson, Anna Barbara Moscicki, Sharon L. Hillier, Betsy Herold

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

The interlaboratory reproducibility of cytokine measurements from cervicovaginal samples by Luminex has not been reported. Using cervicovaginal lavage specimens collected on three study days from 12 women participating in a Phase I microbicide study, we measured a panel of eight cytokines in three independent laboratories. Four (IFN-γ, IL-10, IL-17, and TNF) were below the limit of detection in the majority (85%) of samples in either two or all three laboratories, an observation that may guide analyte selection for future studies. Good interlaboratory agreement (intraclass correlation coefficient, r>0.7) in absolute levels was observed for IL-1β, IL-6, and IL-8, while poor agreement was seen for IFN-α2 (r=0.47). When considering within-subject change from baseline (pre-product, at study-day 0) to either post-product visit (study-days 7 and 14), IL-1β and IL-6 exhibited good interlaboratory agreement (r>0.7), while IFN-α2 and IL-8 did not. Future studies addressing the clinical utility of specific biomarkers of inflammation for microbicide trials should consider reproducibility in the context of defining biologically meaningful thresholds of change for candidate biomarkers, ensuring that such change can be reliably distinguished from background variability.

Original languageEnglish (US)
Pages (from-to)430-434
Number of pages5
JournalCytokine
Volume56
Issue number2
DOIs
StatePublished - Nov 2011

Fingerprint

Biomarkers
Anti-Infective Agents
Interleukin-8
Interleukin-1
Interleukin-6
Cytokines
Safety
Interleukin-17
Therapeutic Irrigation
Interleukin-10
Limit of Detection
Observation
Inflammation
Clinical Studies

Keywords

  • Cervicovaginal secretions
  • Cytokine measurement
  • Microbicide studies
  • Multiplex methods
  • Reproducibility

ASJC Scopus subject areas

  • Immunology
  • Immunology and Allergy
  • Hematology
  • Biochemistry
  • Molecular Biology

Cite this

Interlaboratory reproducibility of female genital tract cytokine measurements by Luminex : Implications for microbicide safety studies. / Scott, Mark E.; Wilson, Sarah S.; Cosentino, Lisa A.; Richardson, Barbra A.; Moscicki, Anna Barbara; Hillier, Sharon L.; Herold, Betsy.

In: Cytokine, Vol. 56, No. 2, 11.2011, p. 430-434.

Research output: Contribution to journalArticle

Scott, Mark E. ; Wilson, Sarah S. ; Cosentino, Lisa A. ; Richardson, Barbra A. ; Moscicki, Anna Barbara ; Hillier, Sharon L. ; Herold, Betsy. / Interlaboratory reproducibility of female genital tract cytokine measurements by Luminex : Implications for microbicide safety studies. In: Cytokine. 2011 ; Vol. 56, No. 2. pp. 430-434.
@article{c6b1e953059646969d9194d8e57c4e2c,
title = "Interlaboratory reproducibility of female genital tract cytokine measurements by Luminex: Implications for microbicide safety studies",
abstract = "The interlaboratory reproducibility of cytokine measurements from cervicovaginal samples by Luminex has not been reported. Using cervicovaginal lavage specimens collected on three study days from 12 women participating in a Phase I microbicide study, we measured a panel of eight cytokines in three independent laboratories. Four (IFN-γ, IL-10, IL-17, and TNF) were below the limit of detection in the majority (85{\%}) of samples in either two or all three laboratories, an observation that may guide analyte selection for future studies. Good interlaboratory agreement (intraclass correlation coefficient, r>0.7) in absolute levels was observed for IL-1β, IL-6, and IL-8, while poor agreement was seen for IFN-α2 (r=0.47). When considering within-subject change from baseline (pre-product, at study-day 0) to either post-product visit (study-days 7 and 14), IL-1β and IL-6 exhibited good interlaboratory agreement (r>0.7), while IFN-α2 and IL-8 did not. Future studies addressing the clinical utility of specific biomarkers of inflammation for microbicide trials should consider reproducibility in the context of defining biologically meaningful thresholds of change for candidate biomarkers, ensuring that such change can be reliably distinguished from background variability.",
keywords = "Cervicovaginal secretions, Cytokine measurement, Microbicide studies, Multiplex methods, Reproducibility",
author = "Scott, {Mark E.} and Wilson, {Sarah S.} and Cosentino, {Lisa A.} and Richardson, {Barbra A.} and Moscicki, {Anna Barbara} and Hillier, {Sharon L.} and Betsy Herold",
year = "2011",
month = "11",
doi = "10.1016/j.cyto.2011.06.011",
language = "English (US)",
volume = "56",
pages = "430--434",
journal = "Cytokine",
issn = "1043-4666",
publisher = "Academic Press Inc.",
number = "2",

}

TY - JOUR

T1 - Interlaboratory reproducibility of female genital tract cytokine measurements by Luminex

T2 - Implications for microbicide safety studies

AU - Scott, Mark E.

AU - Wilson, Sarah S.

AU - Cosentino, Lisa A.

AU - Richardson, Barbra A.

AU - Moscicki, Anna Barbara

AU - Hillier, Sharon L.

AU - Herold, Betsy

PY - 2011/11

Y1 - 2011/11

N2 - The interlaboratory reproducibility of cytokine measurements from cervicovaginal samples by Luminex has not been reported. Using cervicovaginal lavage specimens collected on three study days from 12 women participating in a Phase I microbicide study, we measured a panel of eight cytokines in three independent laboratories. Four (IFN-γ, IL-10, IL-17, and TNF) were below the limit of detection in the majority (85%) of samples in either two or all three laboratories, an observation that may guide analyte selection for future studies. Good interlaboratory agreement (intraclass correlation coefficient, r>0.7) in absolute levels was observed for IL-1β, IL-6, and IL-8, while poor agreement was seen for IFN-α2 (r=0.47). When considering within-subject change from baseline (pre-product, at study-day 0) to either post-product visit (study-days 7 and 14), IL-1β and IL-6 exhibited good interlaboratory agreement (r>0.7), while IFN-α2 and IL-8 did not. Future studies addressing the clinical utility of specific biomarkers of inflammation for microbicide trials should consider reproducibility in the context of defining biologically meaningful thresholds of change for candidate biomarkers, ensuring that such change can be reliably distinguished from background variability.

AB - The interlaboratory reproducibility of cytokine measurements from cervicovaginal samples by Luminex has not been reported. Using cervicovaginal lavage specimens collected on three study days from 12 women participating in a Phase I microbicide study, we measured a panel of eight cytokines in three independent laboratories. Four (IFN-γ, IL-10, IL-17, and TNF) were below the limit of detection in the majority (85%) of samples in either two or all three laboratories, an observation that may guide analyte selection for future studies. Good interlaboratory agreement (intraclass correlation coefficient, r>0.7) in absolute levels was observed for IL-1β, IL-6, and IL-8, while poor agreement was seen for IFN-α2 (r=0.47). When considering within-subject change from baseline (pre-product, at study-day 0) to either post-product visit (study-days 7 and 14), IL-1β and IL-6 exhibited good interlaboratory agreement (r>0.7), while IFN-α2 and IL-8 did not. Future studies addressing the clinical utility of specific biomarkers of inflammation for microbicide trials should consider reproducibility in the context of defining biologically meaningful thresholds of change for candidate biomarkers, ensuring that such change can be reliably distinguished from background variability.

KW - Cervicovaginal secretions

KW - Cytokine measurement

KW - Microbicide studies

KW - Multiplex methods

KW - Reproducibility

UR - http://www.scopus.com/inward/record.url?scp=80053310620&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80053310620&partnerID=8YFLogxK

U2 - 10.1016/j.cyto.2011.06.011

DO - 10.1016/j.cyto.2011.06.011

M3 - Article

VL - 56

SP - 430

EP - 434

JO - Cytokine

JF - Cytokine

SN - 1043-4666

IS - 2

ER -